论文部分内容阅读
目的对多索茶碱治疗支气管哮喘的临床疗效进行分析。方法 76例支气管哮喘患者,随机分为对照组与观察组,每组38例。对照组给予多索茶碱治疗,观察组给予氨茶碱治疗,对比两组疗效。结果观察组总有效率为92.1%高于对照组的71.1%(P<0.05)。两组治疗后第1秒最大呼气量(FEV1)、最大呼气流速(PEF)均显著升高,且观察组治疗后FEV1、PEF均显著高于对照组(P<0.05)。结论多索茶碱对支气管哮喘患者有良好的治疗效果,可有效改善患者肺功能,用药安全性高,值得在临床中推广。
Objective To analyze the clinical efficacy of doxofylline in the treatment of bronchial asthma. Methods 76 patients with bronchial asthma were randomly divided into control group and observation group, with 38 cases in each group. The control group was given doxofylline, and the observation group was treated with aminophylline, comparing the two groups. Results The total effective rate in the observation group was 92.1% higher than that in the control group (71.1%, P <0.05). The maximum expiratory volume (FEV1) and maximum expiratory flow rate (PEF) of the two groups after treatment were significantly increased, and FEV1, PEF in the observation group after treatment were significantly higher than the control group (P <0.05). Conclusion Doxofylline has a good therapeutic effect on patients with bronchial asthma, which can effectively improve the lung function of patients and is safe in use. It is worth to be popularized in clinic.